Figure 8.

Improvement of host defense against EHEC infection by C-L. The number of bacterial CFUs transferred to the liver (A) and spleen (B) on day 3 after infection are shown. The control group was orally administered 100 μL sterile PBS; the EHEC group was orally administered 100 μL sterile PBS containing 1 × 10⁸ CFUs EHEC O157:H7; the EHEC+Enro and EHEC+C-LM groups were administered 100 μL sterile PBS containing 1 × 10⁸ CFUs EHEC O157:H7 and then treated by i.p. injection with 8 mg/kg Enro and C-L, respectively, once/day for 3 days. The data are shown as the mean ± standard deviation (n = 5). NS, P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.